about
Morphometric Characterization of Rat and Human Alveolar Macrophage Cell Models and their Response to Amiodarone using High Content Image Analysis.Pharmacological Threat to Lungs: A Case Series and Literature Review.The diagnostic utility of chest computed tomography scoring for the assessment of amiodarone-induced pulmonary toxicity.Bortezomib therapy-related lung disease in Japanese patients with multiple myeloma: incidence, mortality and clinical characterizationPrehospital amiodarone may increase the incidence of acute respiratory distress syndrome among patients at risk.Association of amiodarone use with acute pancreatitis in patients with atrial fibrillation: a nested case-control study.Ultrastructural Changes in Rat's Atrial Cardiomyocytes After Short Term Administration of Amiodarone and Possible Protective Role of Vitamin E.Anti-arrhythmic medications increase non-cardiac mortality - A meta-analysis of randomized control trialsAcute fibrinous and organizing pneumonia and undifferentiated connective tissue disease: a case report.Management of amiodarone-related thyroid problems48-Year-old woman with dyspnea, cough, and weight lossIn vitro exposure of precision-cut lung slices to 2-(4-amino-3-methylphenyl)-5-fluorobenzothiazole lysylamide dihydrochloride (NSC 710305, Phortress) increases inflammatory cytokine content and tissue damage.Dronedarone-associated acute renal failure: evidence coming from the Italian spontaneous ADR reporting databaseVery early onset of amiodarone-induced pulmonary toxicity.Risk of Cardiovascular Events, Stroke, Congestive Heart Failure, Interstitial Lung Disease, and Acute Liver Injury: Dronedarone versus Amiodarone and Other Antiarrhythmics.Drug-induced interstitial lung disease: mechanisms and best diagnostic approaches.Bronchiolitis: adopting a unifying definition and a comprehensive etiological classification.Pharmacokinetic and pharmacodynamic profile of dronedarone , a new antiarrhythmic agent for the treatment of atrial fibrillation.Antiarrhythmic Drug Therapy for Rhythm Control in Atrial Fibrillation.A systematic assessment of mitochondrial function identified novel signatures for drug-induced mitochondrial disruption in cells.Sotalol versus Amiodarone in Treatment of Atrial Fibrillation.Amiodarone-induced loculated pleural effusion without pulmonary parenchymal involvement: A case report and literature review.A novel amiodarone-eluting biological glue for reducing postoperative atrial fibrillation: first animal trial.Early Amiodarone-Induced Pulmonary Toxicity after Endovascular Aneurysm Repair: A Case Report.Rapid onset of amiodarone induced pulmonary toxicity after lung lobe resection - A case report and review of recent literature.A case study of bofutsushosan-induced pulmonary injury in a patient: Case report.Severe amiodarone induced pulmonary toxicity.Effect of stem cell therapy on amiodarone induced fibrosing interstitial lung disease in albino rat.Herb-Drug Interaction of Paullinia cupana (Guarana) Seed Extract on the Pharmacokinetics of Amiodarone in Rats.Class III antiarrhythmic drugs amiodarone and dronedarone impair KIR 2.1 backward trafficking.Coadministration of Atorvastatin and Amiodarone Increases the Risk of Pulmonary Fibrosis in Rats.The 3D OrbiSIMS-label-free metabolic imaging with subcellular lateral resolution and high mass-resolving power.Impact of Olmesartan Medoxomil on Amiodarone-Induced Pulmonary Toxicity in Rats: Focus on Transforming Growth Factor-ß1.Effect of selective LRRK2 kinase inhibition on nonhuman primate lung.Pleiotropic actions of amiodarone: still puzzling after half a century.Modeling of Amiodarone Effect on Heart Rate Control in Critically Ill Patients with Atrial Tachyarrhythmias.The effect of long-term amiodarone administration on myocardial fibrosis and evolution of left ventricular remodeling in a porcine model of ischemic cardiomyopathy.In vitro study on the pulmonary cytotoxicity of amiodarone.
P2860
Q30313151-D8FB1984-31E0-475A-BC2C-C18A4289203CQ33787981-224B7154-49C0-47A4-ACB8-0994FCBC3722Q34451378-F0EAF978-E48A-4470-B965-4A4CEE4A37E4Q35051496-C1B15759-1A9E-4F9D-AAC8-3643A5FEF14CQ35148146-3069B3C7-E9B6-43D7-BA64-631E405E629CQ35931277-A3B9B686-FB70-4D13-BC8F-808467EC8BAEQ36038058-21F4E2B8-5BBA-4D32-BD18-629F8D2AF5C3Q36063724-16C52071-23CA-408D-A381-AAA0788F6D07Q36169341-A9CA769B-6DEB-4B2D-9A52-8E373A401917Q36328015-762C711E-727B-44B1-B33D-E298DE5E92A4Q36495151-424C294D-4AE3-4001-BAD7-B4D0218B0094Q36551461-4DB3DD01-4E7F-4F0C-9086-7DE855C01440Q36793003-70550561-0312-4CBA-86BF-5EE3D64ADC25Q37316803-79CCECE2-0257-49A2-A7DB-FB5083B1245FQ37496030-3CE23D62-E44C-493A-AE1D-9FBCBDE70A57Q38014958-B4033C85-0228-4920-B1F8-93EE2FAD3B4AQ38111794-6649D85A-723F-4106-81DA-5E0AC610BC8FQ38263224-BB9FAB6F-EF25-407F-B19A-856973B36137Q38853630-FD3CAC4F-938B-45B7-BC9F-31264777E914Q38962365-5E7E1572-74BA-41F2-BD2A-6341583FFECEQ39026541-338F4666-6B47-4C05-8F8F-9395A5948B42Q39157088-4728CE1F-9D92-4A2F-B21B-D181D3A765F4Q39207992-2392D139-CDB7-4FC5-A77F-1211C69EB481Q40958877-16988D80-A03E-4E60-81C5-18199332D533Q41192391-F1975BD3-BE95-4F4C-82CF-7561C15F71C1Q41380898-2C2B9188-A934-433F-903A-DF2D99286873Q41963030-CF4BC415-8C86-4D01-8C27-43893403493CQ42030253-377DBC95-138C-47B9-8815-0168DFCD8F92Q42098545-A4FF9A8A-AE00-42B3-A13A-28E4C326C61DQ42365788-4C41A67B-5DBA-4680-8787-91FB79EE8180Q42756330-468C3A47-B7C8-4C86-BA44-F9F9F5C5D514Q46262837-123B8371-3F43-4036-86C6-AC01B7EF37CCQ46608132-CEC36BA8-B050-43F0-8F3C-2763A3E7CF91Q46777308-C81F8C05-CC6A-4C95-8994-30A0CCCCDC79Q46907800-BB4ACAEE-C21D-4B2C-BD8B-200E666A20C0Q47582251-A754804D-6640-4A81-904A-6F452C457FB7Q49497144-D620E443-D933-471E-86C2-2B03A47B65F1Q50935375-22B4723D-5FD7-4713-B63F-ECE3844AAC69
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on July 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Amiodarone: review of pulmonary effects and toxicity.
@en
Amiodarone: review of pulmonary effects and toxicity.
@nl
type
label
Amiodarone: review of pulmonary effects and toxicity.
@en
Amiodarone: review of pulmonary effects and toxicity.
@nl
prefLabel
Amiodarone: review of pulmonary effects and toxicity.
@en
Amiodarone: review of pulmonary effects and toxicity.
@nl
P2093
P2860
P1433
P1476
Amiodarone: review of pulmonary effects and toxicity.
@en
P2093
Christina Triantafillidou
Despoina Markoulaki
Effrosyni D Manali
Likurgos Kolilekas
Spyros A Papiris
P2860
P304
P356
10.2165/11532320-000000000-00000
P577
2010-07-01T00:00:00Z
P6179
1039300123